Barcelona

• Estudio enmascarado, controlado con placebo, aleatorizado, piloto, de ApTOLL para el tratamiento de pacientes con ictus isquémico agudo a ni … Not authorised
  2023-504015-32-00 4 Acute Ischemic Stroke (AIS)
• A Phase 1/Phase 2 Trial to Evaluate Safety, Immunogenicity and PSA Response of VTP-850 Prostate Cancer Immunotherapeutic in Men with Biochem … Not authorised
  2023-504066-39-00 7 Prostate Cancer
• Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Not authorised
  2023-504231-41-00 10 Locally advanced or metastatic urothelial cancer
• A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours Not authorised
  2023-504246-64-00 9 Relapsed/refractory neuroblastoma and other solid tumours
• HARMONi-3 Not authorised
  2023-504989-37-00 5 Metastatic Squamous Non-small Cell Lung Cancer
• Dose expansion, safety and efficacy study of intravesical instillation of TARA-002 in adults with high-grade non-muscle invasive bladder can … Not authorised
  2023-505062-28-00 9 Non-muscle invasive bladder cancer
• A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) - targeting, Bif … Not authorised
  2023-505334-10-00 7 Unresectable, Locally Advanced, or Metastatic Solid Tumors
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno … Not authorised
  2023-506014-47-00 9 Resected (R0 or R1) pancreatic ductal adenocarcinoma
• A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCER Not authorised
  2023-508058-24-00 1 LOCALLY ADVANCED OR METASTATIC LOW TUMOR VOLUME COLORECTAL CANCER
• Evaluation of the safety and efficacy of the drug AL8326 in the post-first treatment of small cell lung cancer. Not authorised
  2023-509067-24-00 4 Small Cell Lung Cancer (SCLC) patients who need ≥2nd line treatment wi
• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pig … Not authorised
  2024-511181-36-00 5 X-linked retinitis pigmentosa (XLRP)
• A phase 2 study to research the safety and efficacy of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with acti … Not authorised
  2024-512369-14-00 4 Non-small cell lung cancer (NSCLC).
• A study to test a new immunotherapy, ABX-001, alone and in combination with the marketed drug, pembrolizumab, for the treatment of tumors pr … Not authorised
  2024-512403-39-00 1 Advanced Solid Tumors Who Are Beyond Standard of Care
• Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Not authorised
  2024-514411-95-00 4 Amnestic mild cognitive impairment (aMCI, single or multi-domain) or e
• Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas Not authorised
  2024-514827-40-00 9 Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignan
• A trial to learn how ceralasertib affects the way certain medications move throughout the body over time and how safe it is to use ceralaser … Not authorised
  2024-516611-24-00 3 Advanced solid tumour
• A Phase I Interventional Open-Label, Non-Randomized Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacody … Not authorised
  2024-516660-28-00 1 Locally advanced, recurrent, or metastatic breast, gastric, endometria
• Phase I-Ib clinical trial of safety and immunobiology of prophylactic infusion of lymphocytes and NK cells after Allo-HCT. Not authorised
  2024-517002-28-00 3 graft-versus-host disease
• Testing the safety and efficacy of combining biologic drugs in Rheumatoid and Psoriatic Arthritis Not authorised
  2024-518011-19-00 4 Psoriatic Arthritis
• A study to investigate WEF-001 in patients with Advanced KRAS-Mutant Solid Tumours. Not authorised
  2024-518644-21-00 9 Advanced KRAS- Mutant Solid Tumours
• Phase I, single and multiple ascending dose, randomized, double-blind, placebo-controlled, parallel-group clinical trial to evaluate the saf … Not authorised
  2024-518758-18-00 1 Diabetic retinopathy.
• A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors Not authorised
  2024-519862-33-00 1 Platinum-resistant ovarian cancer (PROC)
• A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Po … Not authorised
  2025-521052-35-00 7 Patients with HER2Positive Advanced Breast Cancer
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 5 Schizophrenia

Showing 25–48 of 3,391 trials